8 years ago

Oxford Genetics Raises £7.5 Million to Expand its Synthetic Biology Capabilities

  • Oxford Genetics, a UK-based developer of innovative synthetic biology-based technologies, has secured a £7.5m investment from existing investor Mercia Technologies and Invesco Perpetual

  • The funding will be used to expand the company's facilities in the UK and open a new office in Boston, US

  • The company will also invest in research and development to grow its intellectual property portfolio and technology-enabled licensing business.

      • ProblemTechnology

      "Biologics discovery, development, and delivery is slow, expensive, and inefficient, hindering the development of new treatments."

      Solution

      "Oxford Genetics is developing innovative synthetic biology-based technologies to make biologics discovery, development, and delivery faster, cheaper, and more efficient."

      Covered on